Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,237-1,248 of 1,909
Drug study icon
CompletedNCT00240721

Effectiveness of effectiveness and Safety of Topiramate in Bipolarity

This study is completed. It is testing effectiveness and Safety of Topiramate for Bipolarity.

Location not clearly listed
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.Over 16 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT03818256

Safety study of safety, Efficacy, and Pharmacokinetics of Miricorilant in schizophrenia

This study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.

Multiple locations, including Bentonville
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Corcept Therapeutics
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT01072929

Armodafinil Treatment for depression

This study is completed in the United States. It is testing armodafinil Treatment for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Cephalon
Condition
Bipolarity, Depression
Device study icon
UnknownNCT06422559

Accelerated Intermittent Theta Burst Stimulation in Unipolar Versus Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Al Mansurah
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Egypt
Sponsor
Mansoura University
Condition
Bipolarity, Depression
Drug study icon
WithdrawnNCT01981811

Medical Information Device #1 for schizophrenia

This study was withdrawn in the United States. It is testing Medical Information Device #1 for schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
TerminatedNCT01467700

Ramelteon Sublingual for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Depression, Bipolarity
Drug study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study was terminated in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
WithdrawnNCT00327756

Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT02478788

Neuroimaging Study of Risk Factors for Adolescent Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, ADHDBehavioralFrom 10 Years to 18 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity, ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.